ACSL1 and metabolic dysfunction-associated steatotic liver disease: COS2 promoted the expression of gene and protein levels of ACSL1, CPT1A, and CPT2 to facilitate the rate-limited process of lipolysis, demonstrating the internal mechanism of COS2 in improving hepatic lipid metabolism of NAFLD in ob/ob−/− mice.